Share Name Share Symbol Market Type Share ISIN Share Description
Cathay Intl Ld LSE:CTI London Ordinary Share BMG1965E1030 COM SHS $0.05
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 8.00p 7.75p 8.25p 8.00p 8.00p 8.00p 0 06:39:02
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 95.9 -5.8 -2.5 - 29.75

Cathay Intl Ld Share Discussion Threads

Showing 1 to 14 of 75 messages
Chat Pages: 3  2  1
DateSubjectAuthorDiscuss
09/4/2009
13:20
good results and share price move
queeny2
09/11/2008
10:07
jerry - weren't the A's redundant on the issue of the common shares? regards
targatarga
28/7/2008
09:44
I hold CTI shares - both 'common' shares and 'A' shares. Can anyone please tell me if there is a market for the 'A' shares?
jerrylatham
10/7/2008
08:11
awaiting news?
targatarga
09/11/2007
17:23
Stewacg I agree with you but i cannot find any shares in meaningful size without paying about 10% above the quote. It is very tightly held and sellers seem hard to force out despite the price rise. I have bid for 100k (c£15,000) but with no joy. Was offered 5,000 but hardly seems worthwhile after dealing costs.
davey3
09/11/2007
07:44
I bought too, several plus years ago, but only have a small stake so have not paid too much attention to it. Will be pleased if this finally starts showing some life!
stewartf
08/11/2007
19:11
I don't get this. Now CTI are third on the chart price breakout leaderboard & have broken the 5 year chart despite very nervous markets and still no responses to my message above.
stewacg
06/11/2007
21:08
Why does no-one ever contribute to this board? I bought into Cathay several years ago since it was valued so hideously low against assets (as it still is). There were risks then, as the business was losing money and there was much to do to improve the fabric of their luxury hotel. That is all behind them, with the effort rewarded by a long term management deal with Intercontinental. If that doesn't guarantee long term high room occupancy rates, nothing will. Then there is the growing & profitable Chinese pharmaceutical business. This looks to be the intended direction for the company now that they are freed from worrying about the hotel business. There is slow accumulation going on now, but to me the 5 year chart looks like it may be about to break. If it does, I think that things could get interesting. Anyone agree or disagree?
stewacg
14/9/2007
15:09
Results look good.!!!
topinfo
14/9/2007
15:08
Wots up here then.??
topinfo
17/7/2007
11:06
Davey3 - these have always been a rollercoaster. luckily i sold most of mine at 13p [amazing for me]. Revamping of hotels constantly hold back profits. Who knows what joy the pharma side will bring! regards
targatarga
16/7/2007
16:05
Bit of fall today! Anyone got any info this stock? Looking at the website it seems that it is a chinese pharma company that also owns a luxury hotel in China. Could be a buying opportunity
davey3
06/6/2006
13:36
PRELIMINARY RESULTS FOR THE YEAR ENDED 31 DECEMBER 2005 CHAIRMAN'S STATEMENT INTRODUCTION Repositioning was the theme for Cathay International Holdings Limited in 2005. We acquired a pharmaceutical business to complement our biotech investments in the fast growing and changing China market. We also made a major investment in the redesign and renovation of the Landmark Hotel in Shenzhen (the "Hotel") to position the Hotel at the very top end of the market as an all suite luxury business hotel.
queeny2
10/4/2006
14:56
The Financial Times today carried a feature on Chi-Med, part of Hutchison Whampoa, which is planning a £40 million float on AIM shortly. It's a traditional Chinese medicine company. Earlier in the year China Biotech listed on Ofex. The Chinese domestic market is growing at 20% pa, and is set to be world's fifth biggest in 4 years time. What they didn't mention is that there is already a company listed in London, Cathay International (CTI) which has many pharma and biotech ventures in China and a valuation underpinned by its 5 star hotel in Shenzhen, run by a man called WU ZHEN TAO, who has already made a fortune in China from infrastructure projects. He owns a majority of the company. Yes, it's a punt, but they have many strings to their bow in the pharma/bio area, plus they bought a "drug" distribution business with 200 salesmen. They don't have a web-site, year-end results due shortly. Have a crack.
queeny2
Chat Pages: 3  2  1
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20171123 00:16:52